Finance

Beta
Lists
CATX:NYSEAMERICAN
Perspective Therapeutics Inc
$3.94
-2.72%
(-0.11) 1D
$3.90
-1.01% (-0.040)
After hours
Closed: May 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CATX...
Open
$4.06
High
$4.15
Low
$3.90
Mkt. cap
449.34M
Avg. vol.
1.46M
Volume
893.57K
52-wk high
$6.16
52-wk low
$1.96
EPS
-$1.40
Beta
1.75
Shares outstanding
114.05M
No. of employees
163
Open
$4.06
High
$4.15
Low
$3.90
Mkt. cap
449.34M
Avg. vol.
1.46M
Volume
893.57K
52-wk high
$6.16
52-wk low
$1.96
EPS
-$1.40
Beta
1.75
Shares outstanding
114.05M
No. of employees
163
News stories
From sources across the web
Profile
Isoray Inc. is a national isotope-based medical company and the sole producer of Cesium brachytherapy sources, which are expanding brachytherapy treatments for difficult to treat cancers. Isoray is a registered manufacturer with the FDA and holds multiple 510 clearances for brachytherapy devices. The brachytherapy isotopes are sold under the brandname Blu. The company went public in 2005. Isoray’s corporate headquarters is located at 350 Hills Street, Suite 106, Richland WA 99354. Wikipedia
About Perspective Therapeutics Inc
CEO-
Employees163
Founded2004
HeadquartersSeattle, Washington, United States
SectorBiotechnology
Websiteperspectivetherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
290.00K
209.00K
43.00K
76.00K
Cost of goods sold
16.62M
20.34M
32.92M
21.37M
Cost of revenue
16.62M
20.34M
32.92M
21.37M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.71M
7.73M
6.95M
6.98M
Operating expense
7.71M
7.73M
6.95M
6.98M
Total operating expenses
24.33M
28.07M
39.88M
28.36M
Operating income
-24.04M
-27.86M
-39.83M
-28.28M
Other non operating income
-
-
-
-
EBT including unusual items
-22.00M
-25.97M
-38.28M
-26.19M
EBT excluding unusual items
-22.00M
-25.97M
-38.28M
-26.19M
Income tax expense
-
-
-793.00K
-
Effective tax rate
-
-
2.07%
-
Other operating expenses
-
-
-
-
Net income
-21.48M
-25.97M
-37.49M
-26.19M
Net profit margin
-7,408.62%
-12,425.36%
-87,186.05%
-34,459.21%
Earnings per share
-0.30
-0.35
-0.51
-0.25
Interest and investment income
2.16M
1.96M
1.61M
2.20M
Interest expense
-119.00K
-65.00K
-64.00K
-105.00K
Net interest expenses
2.04M
1.89M
1.55M
2.09M
Depreciation and amortization charges
-
-
-
-
EBITDA
-23.31M
-27.09M
-38.83M
-27.16M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer